IMCImmuronIMC info
$0.05info-1.19%24h
Global rank
Market cap$11.80M
Change 7d-1.19%
YTD Performance7.79%
SP500 benchmarkUnderperform
P/E-3.12
P/S10.49
Revenue$1.12M
Earnings-$2.36M
Dividend yield-
Main Sector
Healthcare
Category

Immuron (IMC) Stock Overview

Immuron Limited, a biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, Israel, Canada, the United States, and internationally. The company operates through two segments, Research and Development, and Hyperimmune Products. It offers Travelan, an over-the-counter medicine to reduce the risk of travelers' diarrhea and risk of minor gastrointestinal disorders, as well as a dietary supplement for support digestive health and gastrointestinal tract protection; and Protectyn, an immune supplement to help maintain a healthy digestive function and liver. The company is also developing Travelan (IMM-124E) to reduce the risk of contracting travelers' diarrhea in the United States, and Travelers' Diarrhea; and IMM-529, for treating patients suffering from recurring clostridium difficile infection. It has a research agreement with Naval Medical Research Center to develop and clinically evaluate a therapeutic targeting Campylobacter and enterotoxigenic Escherichia coli infections; and a collaboration agreement with the Walter Reed Army Institute of Research to develop an oral therapeutic for shigellosis. Immuron Limited was incorporated in 1994 and is headquartered in Carlton, Australia.

IMC Stock Information

Symbol
IMC
Address
62 Lygon StreetCarlton, VIC 3053Australia
Founded
-
Trading hours
10:00 AM - 4:00 PM AEST
Website
https://www.immuron.com.au
Country
🇦🇺 Australia
Phone Number
61 3 9824 5254

Immuron (IMC) Price Chart

-
Value:-

Immuron Overview: Key Details and Summary

Stock data
2023
Change
Price
$0.051721129639323016
N/A
Market Cap
$11.80M
N/A
Shares Outstanding
228.10M
0.23%
Employees
6.00
N/A
Valuation
2023
Change
P/E Ratio
-3.12
N/A
P/S Ratio
10.49
N/A
Earnings
2023
Change
Revenue
$1.12M
N/A
Earnings
-$2.36M
N/A
EPS
-0.0166
N/A
Earnings Yield
-0.321
N/A
Gross Margin
0.7254
N/A
Operating Margin
-1.89
N/A
Net income margin
-2.10
N/A
logo
Facebook Icon
Twitter Icon
Linkedin Icon
© 2024 Topstocks.org